While a previous study introduced IL-15 and CCL19 into CAR-T cells and evaluated the anti-tumor effects using a zebrafish xenotransplantation model (42), mouse xenograft models remain the gold standard for preclinical evaluation of CAR-T cell therapy. The gene discussed is CCL19; the disease is neoplasm.